Top Institutions in RNA Therapeutics and Drug Delivery
Institutions leading in RNA therapeutics and delivery combine expertise in molecular biology, nanotechnology, chemistry, and clinical translation, often integrating advanced polymer chemistry and nanoparticle engineering with in vitro and in vivo validation of RNA delivery systems.
-
#1
Massachusetts Institute of Technology (MIT)
Cambridge, MA
MIT is a global leader in RNA delivery technologies, with pioneering work in lipid nanoparticle systems and polymer-based RNA carriers, supported by strong interdisciplinary research centers such as the Koch Institute for Integrative Cancer Research.
Key Differentiators
- RNA Therapeutics
- Nanomedicine
- Drug Delivery
-
#2
Johns Hopkins University
Baltimore, MD
Johns Hopkins has a robust program in RNA delivery and immunotherapy, with expertise in nanoparticle engineering and clinical translation of RNA-based vaccines and therapeutics.
Key Differentiators
- RNA Therapeutics
- Nanoparticle Drug Delivery
- Immunotherapy
-
#3
University of California, San Francisco (UCSF)
San Francisco, CA
UCSF is recognized for its translational research in RNA biology and delivery, with significant contributions to RNA vaccine development and novel delivery modalities including supramolecular systems.
Key Differentiators
- RNA Therapeutics
- Nanomedicine
- Molecular Medicine
-
#4
University of Pennsylvania
Philadelphia, PA
Penn has a leading gene therapy program with extensive research in RNA delivery platforms, including lipid nanoparticles and polymeric carriers, and a strong focus on clinical translation.
Key Differentiators
- RNA Therapeutics
- Gene Therapy
- Nanotechnology
-
#5
University of Nottingham
Nottingham, Nottinghamshire, UK
The University of Nottingham is emerging as a leader in supramolecular chemistry-based RNA delivery platforms, developing modular and tunable nanoscale carriers with promising preclinical results.
Key Differentiators
- Supramolecular Chemistry
- RNA Therapeutics
- Nanomedicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.